Study guide

2.2 Lactogenesis Stages I, II & III: From Pregnancy Through Established Supply

Certified Lactation Counselor CLC

Track your progress as you read

Finished sections get a check mark.

1 Introduction & CLC Exam Overview

1.1 CLC Exam Facts, Format & Eligibility Pathways 1.2 The ALPP Blueprint: Chronological Periods, Topic Areas & General Principles 1.3 How to Use This Study Guide & a 4-Phase Study Plan

2 Chapter 2: Lactation Physiology I — Hormonal Control & Milk Synthesis

2.1 Hormonal Control of Lactation: Prolactin, Oxytocin & the Let-Down Reflex 2.2 Lactogenesis Stages I, II & III: From Pregnancy Through Established Supply 2.3 Autocrine Control: The Feedback Inhibitor of Lactation (FIL) & Supply-Demand 2.4 Colostrum, Transitional & Mature Milk: Composition Changes Over Time

3 Chapter 3: Lactation Physiology II — Breast & Infant Anatomy

3.1 Breast Anatomy: Alveoli, Ducts, Montgomery Glands & Cooper's Ligaments 3.2 Infant Oral Anatomy & the Suck-Swallow-Breathe Sequence 3.3 Variant Anatomy: Insufficient Glandular Tissue, Breast Surgery & Discrepant Breast Size 3.4 Maternal Endocrine Conditions Affecting Supply: PCOS, Thyroid & Anemia

4 Chapter 4: Latch & Positioning Fundamentals

4.1 Assessing an Effective Latch: Signs & the Lactation Assessment Tool 4.2 Core Feeding Positions: Cradle, Cross-Cradle, Football & Laid-Back 4.3 Confirming Milk Transfer: Nutritive vs. Non-Nutritive Sucking 4.4 Correcting a Shallow Latch & Managing Latch Pain

5 Chapter 5: Milk Transfer Assessment & Feeding Devices

5.1 Assessing Adequate Intake: Output, Weight Gain & Feeding History 5.2 Ankyloglossia (Tongue-Tie) and Its Effect on Feeding 5.3 Nipple Shields: Indications, Risks & Weaning From Use 5.4 Commercial Products: Pumps, Feeders, Bottles & Techniques for Their Use

6 Chapter 6: Maternal Breastfeeding Problems

6.1 Engorgement vs. Mastitis vs. Plugged Ducts: Differentiating Breast Conditions 6.2 Nipple Pain, Vasospasm & Candida (Thrush): Differential Diagnosis 6.3 Managing Oversupply & Low Milk Supply 6.4 Dysphoric Milk Ejection Reflex (D-MER) & Maternal Health Conditions (Cancer, Thyroid) 6.5 Hand Expression: Technique & Indications

7 Chapter 7: Infant Feeding Challenges & Special Health Needs

7.1 Feeding the Premature Infant: Risks, Benefits & Modifications 7.2 Infant Conditions Affecting Feeding: Cleft Lip/Palate, Down Syndrome & Paralysis 7.3 Infant Feeding Challenges: Biting, Refusal, Formula Intolerance & Distractibility

8 Chapter 8: Special Circumstances & Perinatal Mental Health

8.1 Slow Weight Gain: Distinguishing Perceived vs. Actual Insufficient Milk Supply 8.2 Lactation During Mother-Infant Separation: Illness, Hospitalization & Emergencies 8.3 Postpartum Mood & Anxiety Disorders: Screening With the Edinburgh Scale

9 Chapter 9: Maternal & Infant Nutrition

9.1 Benefits of Breastfeeding vs. Risks of Powdered Infant Formula Preparation 9.2 Nutritional Needs & Counseling for Pregnant and Lactating Women 9.3 Complementary Feeding: Timing, Growth Patterns & Micronutrient Needs

10 Chapter 10: Growth, Long-Term Feeding & Weaning

10.1 Contraceptive Options & Child Spacing During Lactation (LAM Method) 10.2 Long-Term Breastfeeding: Tandem Nursing, Nursing Through Pregnancy & Relactation 10.3 Weaning: Gradual and Abrupt Approaches & Counseling Considerations

11 Chapter 11: Core Counseling Skills

11.1 Foundations of Lactation Counseling: History-Taking & Anticipatory Guidance 11.2 Effective Interpersonal Communication & Hands-Off Support Techniques 11.3 Cultural Humility, Cultural Beliefs & Addressing Social Barriers to Breastfeeding 11.4 Counseling Through Real-Life Challenges: Return to Work, School & Unsupportive Workplaces

12 Chapter 12: Public Health, Promotion & Policy

12.1 The Baby-Friendly Hospital Initiative (BFHI): Skin-to-Skin, Rooming-In & Responsive Feeding 12.2 The WHO International Code of Marketing of Breastmilk Substitutes 12.3 Workplace Protections, Sustaining Lactation at Work/School & Community Breastfeeding Coalitions

13 Chapter 13: Professional Ethics & Scope of Practice

13.1 CLC Scope of Practice, Appropriate Referral & Interdisciplinary Collaboration 13.2 ALPP Code of Ethics: Commercial Product Reporting & WHO Code Violations

2.2 Lactogenesis Stages I, II & III: From Pregnancy Through Established Supply

Key Takeaways Explain This Topic AI

Lactogenesis I begins around 16-22 weeks gestation; alveolar cells gain secretory capacity but progesterone/estrogen keep output low.

Lactogenesis II (secretory activation) is triggered by progesterone withdrawal after birth; biochemical onset ~30-40 hours, perceived 'milk coming in' around day 2-3, copious by day 3-5.

Delayed lactogenesis II is defined as onset beyond 72 hours postpartum; risk factors include cesarean birth, obesity, gestational diabetes, retained placenta, hemorrhage, and infrequent removal.

Lactogenesis III (galactopoiesis, ~day 9 onward) marks the shift from hormone-driven to local autocrine (supply-demand) control.

Small day 1-2 colostrum volume is normal physiology, not delayed lactogenesis — the exam expects you to tell these apart.

Last updated: July 2026

Why This Topic Matters on the CLC Exam

The CLC exam's chronological-period axis (Prenatal, Labor/birth/1-2 days, 3-14 days, 15-28 days, and beyond) is built directly on top of the three stages of lactogenesis — the physiological process by which the breast progresses from pregnancy-ready to fully milk-producing. Questions about "when should milk come in," "is this delayed onset a real problem," and "why is day-1 milk volume so small" all depend on knowing exactly which lactogenesis stage a mother is in and what triggers the transition between stages. This is one of the most concretely testable, date-and-number-driven topics on the exam.

Lactogenesis I: The Breast Becomes Capable

Lactogenesis I begins around the mid-point of pregnancy (roughly 16-22 weeks gestation) . During this stage, alveolar cells differentiate into lactocytes and gain the biochemical capacity to secrete colostrum components — but they do not yet produce copious milk. High circulating progesterone and estrogen from the placenta actively suppress full milk secretion during pregnancy, even though prolactin levels are already rising. This is why some pregnant people notice colostrum leaking from the breast in the third trimester: the capacity is present, but placental hormones keep volume low. A CLC should be able to reassure a pregnant client that leaking colostrum prenatally is normal and not a sign that "the milk will run out" before birth.

Lactogenesis II: Secretory Activation

Lactogenesis II , also called secretory activation , is the trigger event most candidates think of as "milk coming in." It is set off by the abrupt withdrawal of progesterone following delivery of the placenta, occurring in the presence of sustained high prolactin and adequate cortisol and insulin. Progesterone drops roughly ten-fold over the first four days postpartum, and once it falls below a threshold, the mammary epithelium undergoes a coordinated shift into full secretory function.

Biochemically, secretory activation begins within about 30-40 hours postpartum (measurable as a rise in milk sodium/potassium ratio changes and lactose concentration).

Subjectively, most mothers perceive "milk coming in" — breast fullness and a surge in volume — around day 2-3 , with copious volume typically established by day 3-5 .

Delayed lactogenesis II is defined as onset beyond 72 hours (3 days) postpartum and is an important clinical red flag.

Risk factors for delayed lactogenesis II that the exam may present in a scenario:

  • Cesarean birth
  • Maternal obesity or higher BMI
  • Gestational diabetes or insulin resistance
  • Retained placental fragments
  • Significant postpartum hemorrhage
  • High maternal stress or prolonged, difficult labor
  • Infrequent or ineffective milk removal in the first 24-48 hours
  • Lactogenesis III: Galactopoiesis — the Shift to Autocrine Control

Lactogenesis III , or galactopoiesis , is the maintenance phase of an established milk supply, generally recognized from about day 9 postpartum onward . The defining feature of this stage is a shift in control mechanism : whereas Lactogenesis I and II are driven mainly by systemic ( endocrine ) hormone changes — progesterone withdrawal, prolactin, cortisol — Lactogenesis III is governed primarily by local, autocrine control within each breast, based on how frequently and completely milk is removed. This sets up the feedback inhibitor of lactation (FIL) mechanism covered in the next section: once supply is established, "more removal = more milk" becomes the operating rule, largely independent of circulating hormone levels.

Stage Timing Trigger Control Type Clinical Marker

Lactogenesis I ~16-22 weeks gestation Alveolar cell differentiation Endocrine (progesterone/estrogen suppress output) Colostrum may leak prenatally

Lactogenesis II Onset ~30-40 hrs postpartum; perceived day 2-3 Progesterone withdrawal + high prolactin/cortisol Endocrine "Milk coming in"; copious volume by day 3-5

Lactogenesis III ~Day 9 postpartum onward Sustained, frequent milk removal Autocrine (local, supply-demand) Volume tracks removal frequency, not hormone levels

A Realistic Exam Scenario

A mother who delivered by unplanned cesarean after a long labor calls on day 4 postpartum, worried that her breasts still feel soft and her newborn seems unsatisfied after every feed. Applying the lactogenesis framework: day 4 is past the typical day 2-3 perception window but not yet past the 72-hour delayed-lactogenesis-II threshold by much, and cesarean birth plus a long labor are both recognized risk factors. The appropriate CLC response is not panic, but a structured plan: verify frequent, effective removal (8-12 times/24 hours), assess latch and transfer, monitor infant output and weight, and refer to the prescribing/attending clinician promptly if there is no clear sign of secretory activation by day 5, or if the mother reports retained placental symptoms (heavy bleeding, fever).

Common Traps

Candidates frequently confuse delayed lactogenesis II (a true physiological/timing problem, past 72 hours) with the normal, expected small volume of colostrum in the first 24-48 hours, which is not delayed at all — it is exactly what a newborn's tiny stomach needs (see the milk-composition section later in this chapter). Do not let an exam item trick you into recommending supplementation or expressing alarm simply because day-1 or day-2 volumes are small; the red flag is the absence of any transition by 72+ hours, combined with risk factors and inadequate infant output.

Key Takeaways for Test Day

Lactogenesis I begins ~16-22 weeks gestation (capacity develops, but progesterone/estrogen suppress output).

Lactogenesis II is secretory activation, triggered by progesterone withdrawal; biochemical onset ~30-40 hours, perceived "milk coming in" day 2-3, copious by day 3-5.

Delayed lactogenesis II = onset beyond 72 hours; risk factors include cesarean birth, obesity, gestational diabetes, retained placenta, hemorrhage, and infrequent removal.

Lactogenesis III (galactopoiesis, ~day 9+) marks the shift from endocrine to autocrine (local, supply-demand) control.

Small colostrum volume in the first 1-2 days is normal, not delayed lactogenesis — don't confuse the two on exam items.